poisar

Stocks · News reference

BTIG Maintains Buy on Kestra Medical Techs, Raises Price Target to $32

Jul 15, 2026, 11:08 AMBenzinga Newsdesk

BTIG analyst Marie Thibault maintains Kestra Medical Techs (NASDAQ:KMTS) with a Buy and raises the price target from $30 to $32.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

KMTS
Source
benzinga
Observed
Jul 15, 2026, 11:08 AM
Checked
Jul 15, 2026, 11:08 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 26, 2026, 10:00 AMNa

    Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

    Kestra Medical Technologies announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience in a newly created role. Kopf, who previously led global customer experience at Insulet Corporation and served as Chief Experience Officer at REI, will oversee the patient experience for the ASSURE WCD device. The appointment aligns with Kestra's investments in commercial capabilities and artificial intelligence initiatives to drive growth and improve patient support throughout their cardiac recovery journey.

    Read original at globenewswire-inc
    KMTS